Solara Active Pharma Sciences (NSE:SOLARAPP1) Other Current Assets: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SOLARAPP1 Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
69 GF Score
Price ₹267.45
GF Value ₹290.11
! 3 Warning Signs
View Full Analysis

What is Solara Active Pharma Sciences Other Current Assets?

Solara Active Pharma Sciences NSE:SOLARAPP1 69 Other Current Assets is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:SOLARAPP1 with a GF Score™ of 69/100 and a GF Value™ of ₹290.11. The stock has 3 warning signs investors should review.

Solara Active Pharma Sciences's other current assets for the quarter that ended in Jun. 2026 was ₹0 Mil.

Solara Active Pharma Sciences's quarterly other current assets increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹416 Mil) but then declined from Mar. 2026 (₹416 Mil) to Jun. 2026 (₹0Mil).

Solara Active Pharma Sciences's annual other current assets declined from Mar. 2024 (₹763 Mil) to Mar. 2025 (₹679 Mil) declined from Mar. 2025 (₹679 Mil) to Mar. 2026 (₹416 Mil).


Solara Active Pharma Sciences Other Current Assets Related Terms


Solara Active Pharma Sciences Other Current Assets Historical Data

* Premium members only.

The historical data trend for Solara Active Pharma Sciences's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solara Active Pharma Sciences Other Current Assets Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 665.70 378.80 763.30 679.30 416.00

Solara Active Pharma Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 697.40 0.00 416.00 0.00
NSE:SOLARAPP1
69GF Score
Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solara Active Pharma Sciences Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of ₹0 Mil mean?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Other Current Assets of ₹0 Mil as of Jun. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Solara Active Pharma Sciences.
Is Solara Active Pharma Sciences' Other Current Assets too high?
Solara Active Pharma Sciences' current Other Current Assets is ₹0 Mil. Overall, Solara Active Pharma Sciences has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Other Current Assets compare to ZTS?
Solara Active Pharma Sciences' Other Current Assets of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Solara Active Pharma Sciences. Solara Active Pharma Sciences's current Other Current Assets is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Other Current Assets of ₹0 Mil. The stock's GF Value™ is ₹290.11, compared to a current price of ₹267.45 — trading 7.8% below its estimated fair value. The current Other Current Assets is ₹0 Mil. Solara Active Pharma Sciences' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Other Current Assets is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?

Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be undervalued. The current stock price of ₹267.45 is trading 7.8% below its estimated GF Value™ of ₹290.11.

Key valuation signals for NSE:SOLARAPP1:

  • Other Current Assets: ₹0 Mil
  • GF Value™: ₹290.11 vs. price of ₹267.45 (7.8% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Solara Active Pharma Sciences Business Description

Other Exchanges SOLARA:India541540:India
Address Phase II - CSIR Road, Module No. 601, 602, 603, Ticel Bio Park, Taramani, Chennai, TN, IND, 600113
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
69GF Score

Get the complete analysis for NSE:SOLARAPP1

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹267.45
Price
₹290.11
GF Value